Company intelligence / Profile preview

CVTFF Pharmaceuticals

Saskatoon, Saskatchewan, Canadacannimed.ca ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

CanniMed Therapeutics was a pioneering Canadian biopharmaceutical company focused on the production and development of pharmaceutical-grade medical cannabis. Originally established as Prairie Plant Systems in 1988, the company became the first licensed producer under Health Canada's medical marijuana regulations. CanniMed specialized in standardized cannabis products, including oils and dried flower, supported by clinical research for indications such as chronic pain and neurological conditions. The company was acquired by Aurora Cannabis in 2018 for approximately $1.1 billion CAD, marking a significant consolidation in the medical cannabis sector.

Therapeutic areas: RheumatologyNeurologyGastroenterology
Modalities: Small moleculePlant-derived extract
Industry: Biotech

Partnerships

PharmaChoice

Beyond the preview

Go deeper on CVTFF Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CVTFF Pharmaceuticals.